We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

92 hedge funds and large institutions have $101M invested in Enzo Biochem, Inc. in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,656% more call options, than puts

Call options by funds: $496K | Put options by funds: $18K

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

12% more capital invested

Capital invested by funds: $90.4M → $101M (+$10.7M)

10% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 29

7% more funds holding

Funds holding: 86 → 92 (+6)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
92
Holders Change
+6
Holders Change %
+6.98%
% of All Funds
2.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
14
Increased
32
Reduced
29
Closed
7
Calls
$496K
Puts
$18K
Net Calls
+$478K
Net Calls Change
+$221K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.89M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.95M
3
Allianz Asset Management
Allianz Asset Management
Germany
+$1.61M
4
GIM
Granahan Investment Management
Massachusetts
+$1.6M
5
Northern Trust
Northern Trust
Illinois
+$1.42M

Top Sellers

Rank Fund Capital Flow
1
PRC
Platte River Capital
Colorado
-$668K
2
VKH
Virtu KCG Holdings
New York
-$625K
3
TC
TFS Capital
Pennsylvania
-$586K
4
CCM
Corsair Capital Management
New York
-$352K
5
Deutsche Bank
Deutsche Bank
Germany
-$245K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.02M +$107K +20,100 +11%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$956K +$4.59K +860 +0.5%
Citadel Advisors
28
Citadel Advisors
Florida
$918K +$489K +91,697 +106%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$903K +$9.76K +1,829 +1%
RFC
30
Russell Frank Company
Washington
$770K +$37.2K +6,969 +5%
BIM
31
Bogle Investment Management
Massachusetts
$723K -$243K -45,590 -25%
Charles Schwab
32
Charles Schwab
California
$703K – – –
SO
33
STRS Ohio
Ohio
$619K -$25.1K -4,700 -4%
BIM
34
BlackRock Investment Management
Delaware
$511K +$11.8K +2,209 +2%
Goldman Sachs
35
Goldman Sachs
New York
$470K -$48.6K -9,105 -9%
GIP
36
Granite Investment Partners
California
$456K +$13.2K +2,470 +3%
PPA
37
Parametric Portfolio Associates
Washington
$409K +$424K +79,387 New
SIM
38
Spark Investment Management
New York
$401K +$280K +52,500 +207%
Connor, Clark & Lunn Investment Management (CC&L)
39
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$378K +$392K +73,420 New
PAM
40
Panagora Asset Management
Massachusetts
$375K -$186K -34,871 -32%
KCM
41
Kempner Capital Management
Texas
$361K – – –
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$323K +$1.91K +358 +0.6%
CCMH
43
Cornerstone Capital Management Holdings
New York
$310K +$258K +48,400 +410%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$293K – – –
ZIM
45
Zacks Investment Management
Illinois
$260K +$270K +50,580 New
AA
46
Ancora Advisors
Ohio
$257K -$213K -40,000 -44%
TA
47
Teachers Advisors
New York
$249K – – –
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$237K -$216K -40,560 -47%
Jacobs Levy Equity Management
49
Jacobs Levy Equity Management
New Jersey
$216K +$72.6K +13,600 +48%
US Bancorp
50
US Bancorp
Minnesota
$214K +$7.47K +1,400 +3%
1
2
3 4

ENZ Hedge Fund Activity: Q3 2014 in Review

92 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2014, worth a combined $101M — up 12% from $90.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ENZ positions and 7 closed out — a net gain of 7 holders — while 32 added to existing stakes and 29 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $2.89M. The largest seller was Platte River Capital, cutting an estimated $668K.

  • 92 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2014, up from 86 in Q2 2014.
  • Funds reported $101M of Enzo Biochem, Inc. stock for Q3 2014, up 12% quarter-over-quarter.
  • 14 funds opened new Enzo Biochem, Inc. positions in Q3 2014 and 7 closed out, a net change of +7 holders.
  • The largest Enzo Biochem, Inc. buyer in Q3 2014 was Wellington Management Group, an estimated $2.89M added.
  • The largest Enzo Biochem, Inc. seller in Q3 2014 was Platte River Capital, an estimated $668K sold.

Based on aggregated 13F filings for Q3 2014.